+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
Male Hypogonadism - Epidemiology Forecast to 2032 - Product Thumbnail Image

Male Hypogonadism - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Plague - Epidemiology Forecast to 2032 - Product Thumbnail Image

Plague - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pleural Effusion - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pleural Effusion - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sinusitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sinusitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Systemic Lupus Erythematosus - Epidemiology Forecast to 2032 - Product Thumbnail Image

Systemic Lupus Erythematosus - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Systemic Mastocytosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Systemic Mastocytosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Graves Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Graves Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gastritis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastritis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Coronary Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute Coronary Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Embolism - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Embolism - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hemorrhoids - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hemorrhoids - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Infantile Spasm - Epidemiology Forecast to 2032 - Product Thumbnail Image

Infantile Spasm - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Amebiasis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Amebiasis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Brucellosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Brucellosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cellulitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cellulitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pharyngitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pharyngitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Actinic Keratosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Actinic Keratosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Neurodermatitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Neurodermatitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Zollinger Ellison Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more